These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 181337)

  • 1. A quantitative analysis of the susceptibility of human leukocytes to transformation by Epstein-Barr virus.
    Katsuki T; Hinuma Y
    Int J Cancer; 1976 Jul; 18(1):7-13. PubMed ID: 181337
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epstein-Barr virus interactions with human lymphocyte subpopulations: virus adsorption, kinetics of expression of Epstein-Barr virus-associated nuclear antigen, and lymphocyte transformation.
    Menezes J; Jondal M; Leibold W; Dorval G
    Infect Immun; 1976 Feb; 13(2):303-10. PubMed ID: 177360
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lymphoblastoid transformation and kinetics of appearance of viral nuclear antigen (EBNA) in cord-blood lymphocytes infected by Epstein-Barr Virus (EBV).
    Yata J; Desgranges C; Nakagawa T; Favre MC; De-The G
    Int J Cancer; 1975 Mar; 15(3):377-84. PubMed ID: 49325
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clonal transformation of human leukocytes by Epstein-Barr virus in soft agar.
    Yamamoto N; Hinuma Y
    Int J Cancer; 1976 Feb; 17(2):191-6. PubMed ID: 175028
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epstein-Barr virus nuclear protein 2 is a key determinant of lymphocyte transformation.
    Cohen JI; Wang F; Mannick J; Kieff E
    Proc Natl Acad Sci U S A; 1989 Dec; 86(23):9558-62. PubMed ID: 2556717
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction of Epstein-Barr virus-associated nuclear antigen during in vitro transformation of human lymphoid cells.
    Leibold W; Flanagan TD; Menezes J; Klein G
    J Natl Cancer Inst; 1975 Jan; 54(1):65-8. PubMed ID: 163326
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Primary immune responses by cord blood CD4(+) T cells and NK cells inhibit Epstein-Barr virus B-cell transformation in vitro.
    Wilson AD; Morgan AJ
    J Virol; 2002 May; 76(10):5071-81. PubMed ID: 11967323
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immune escape by Epstein-Barr virus (EBV) carrying Burkitt's lymphoma: in vitro reconstitution of sensitivity to EBV-specific cytotoxic T cells.
    Masucci MG; Zhang QJ; Gavioli R; De Campos-Lima PO; Murray RJ; Brooks J; Griffin H; Ploegh H; Rickinson AB
    Int Immunol; 1992 Nov; 4(11):1283-92. PubMed ID: 1282031
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanisms of enhancement of Epstein-Barr virus-induced transformation of peripheral blood lymphocytes by a tumor promoter, TPA, with special reference to lowering of cytotoxicity of T cells.
    Harada S; Katsuki T; Yamamoto H; Hinuma Y
    Int J Cancer; 1981 May; 27(5):617-23. PubMed ID: 6270019
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epstein-Barr virus susceptibility of normal human B lymphocyte populations.
    Aman P; Ehlin-Henriksson B; Klein G
    J Exp Med; 1984 Jan; 159(1):208-20. PubMed ID: 6319530
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Appearance of Epstein-Barr virus nuclear antigen in human cordblood lymphocytes.
    Wright J; Falk L; Deinhardt F
    IARC Sci Publ (1971); 1975; (11 Pt 1):409-14. PubMed ID: 190146
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heterogeneity of EBV-transformable human B lymphocyte populations.
    Chan MA; Stein LD; Dosch HM; Sigal NH
    J Immunol; 1986 Jan; 136(1):106-12. PubMed ID: 2999241
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Simple assay method for susceptibility of human lymphocytes to Epstein-Barr virus infection.
    Takada K; Osato T
    Intervirology; 1982; 18(1-2):87-91. PubMed ID: 6288618
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interleukin 15-mediated induction of cytotoxic effector cells capable of eliminating Epstein-Barr virus-transformed/immortalized lymphocytes in culture.
    Sharif-Askari E; Fawaz LM; Tran P; Ahmad A; Menezes J
    J Natl Cancer Inst; 2001 Nov; 93(22):1724-32. PubMed ID: 11717333
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of a second Epstein-Barr virus-determined nuclear antigen associated with the BamHI WYH region of EBV DNA.
    Dillner J; Kallin B; Ehlin-Henriksson B; Timar L; Klein G
    Int J Cancer; 1985 Mar; 35(3):359-66. PubMed ID: 2982749
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epstein-Barr virus nuclear antigen 2 specifically induces expression of the B-cell activation antigen CD23.
    Wang F; Gregory CD; Rowe M; Rickinson AB; Wang D; Birkenbach M; Kikutani H; Kishimoto T; Kieff E
    Proc Natl Acad Sci U S A; 1987 May; 84(10):3452-6. PubMed ID: 3033649
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [IFN production by Epstein-Barr virus in human mononuclear leukocytes and suppression of the virus-induced transformation by the endogenous interferon].
    Kikuta H
    Hokkaido Igaku Zasshi; 1986 Jan; 61(1):46-57. PubMed ID: 3009290
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Analysis of Epstein-Barr virus transformation of human lymphocytes: susceptibility of B lymphocyte subpopulations and differentiation stage of the transformed cells].
    Koizumi S
    Hokkaido Igaku Zasshi; 1985 Sep; 60(5):724-34. PubMed ID: 3000906
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mitotic EBNA-positive lymphocytes in peripheral blood during infectious mononucleosis.
    Robinson J; Smith D; Niederman J
    Nature; 1980 Sep; 287(5780):334-5. PubMed ID: 6252472
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of the transformation of human lymphocytes by Epstein-Barr virus. II. Abortive response of leukemic cells to the transforming virus.
    Takada K; Yamamoto K; Osato T
    Intervirology; 1980; 13(4):223-31. PubMed ID: 6248483
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.